Most small and mid-sized sponsors face the same problem. Clinical supply is critical, but it doesn't justify a full-time senior hire — and large service providers won't sell below a full engagement. The result is a gap covered by someone already stretched across three other roles.
Sponsor-side clinical supply management across cold-chain biologics programmes, from first-in-human studies to global pivotal trials exceeding 10,000 patients.
Figures aggregate roles held across commercial pharmaceutical supply chain and clinical trial supply management. Sponsor and programme names withheld under confidentiality.
Standing senior access without execution ownership. Monthly supply risk review, protocol and amendment review from a supply-feasibility standpoint, vendor selection input, and on-call escalation support.
A named senior lead owning clinical supply strategy and execution oversight across a defined set of studies. Typically two to three days a week over six to twelve months.
Full functional coverage during a vacancy, a CDMO transition, or a programme scale-up. Including handover to the permanent hire when they arrive.
Every engagement opens with a written Supply Risk Baseline — every open supply risk across your studies, scored, with immediate actions flagged. Delivered by day ten.
It is also available as a standalone piece of work, independent of any longer engagement — and it gives whoever you eventually hire a proper starting point.
Tell us what your programme looks like and where the gap sits. We will come back with the engagement model that fits — and what the first ten days would cover.
You’ll have a reply within one business day.